Polymeric conjugates of antitumor agents
OwnerAntonio Suarato, Francesco Angelucci +4inventors
InventorsAntonio Suarato, Francesco Angelucci, Michele Caruso, Alessandro Scolaro, Daniele Volpi, Moreno Zamai
Life of this patent
Estimating the term…
Loading patent…
OwnerAntonio Suarato, Francesco Angelucci +4inventors
InventorsAntonio Suarato, Francesco Angelucci, Michele Caruso, Alessandro Scolaro, Daniele Volpi, Moreno Zamai
Estimating the term…
Water soluble polymeric conjugates of antitumor agents of formula (A) P-[W2]p-S0-[W1]r-[D] wherein: P is a water soluble polymer; [W1] is a residue of formula —HN-Z1-CO— in which Z1 represents a linear or branched C2-C12 alkylene chain or the residue of formula —C6HC—CH2—O—; [W2] is a residue of formula —HN-Z2-CO— in which Z2 represents a C2-C12 linear or branched alkylene chain; p and r are 0 or 1; S0 is a peptide that selectively is cleaved at the tumor site mainly by the action of the matrix metalloproteinases gelatinase; [D] is the residue of an antitumor agent. The conjugates possess enhanced antitumor activity and decreased toxicity with respect to the free drug. A process for their preparation, useful intermediates and pharmaceutical compositions containing them are also described.
A polymeric drug-conjugate of formula (A)
A polymeric conjugate according to any one of the preceding claims wherein the antitumor agent [D] is a cytotoxic agent belonging to the class of vinca alkaloids, anthracyclines, taxanes, cytotoxic nucleosides, camptothecins, podophyllotoxins, or alkylating agents.
A polymeric conjugate according to any one of the preceding claims wherein [P] is a water soluble polymer based on N-(2-hydroxypropyl)methacryloylamide.
A polymeric conjugate as defined in any one of claims 1 to 18 or 14 or a compound of formula (1) or (1′) as defined in claim 11 for use in a method of treatment of the human or animal body by therapy.
Dependencies are inferred from the claim text.